FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yong Li

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Concepts & Ideas

Molecular Sequence Data

Procedures

Co-author Network

Publications

TOP 3
Jennifer A Wargo; Paul F Robbins; Yong Li; Yangbing Zhao; Mona El-Gamil; Diana Caragacianu; Zhili Zheng; Julie A Hong; Stephanie Downey; David S Schrump; STEVEN ROSENBERG; Richard A Morgan
Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression.
Maria R Parkhurst; John P Riley; Paul F Robbins; Jayne Joo; Yong Li; Zhiya Yu; STEVEN ROSENBERG
Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells.
Marybeth S Hughes; Yik Y L Yu; Mark E Dudley; Zhili Zheng; Paul F Robbins; Yong Li; John R Wunderlich; Robert G Hawley; Morvarid Moayeri; STEVEN ROSENBERG; Richard A Morgan
Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yong Li (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Jennifer A Wargo; Paul F Robbins; Yong Li; Yangbing Zhao; Mona El-Gamil; Diana Caragacianu; Zhili Zheng; Julie A Hong; Stephanie Downey; David S Schrump; STEVEN ROSENBERG; Richard A Morgan
Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression.
Cancer immunology, immunotherapy : CII 2009;58(3):383-94.
2009: Maria R Parkhurst; John P Riley; Paul F Robbins; Jayne Joo; Yong Li; Zhiya Yu; STEVEN ROSENBERG
Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(1):169-80.
2005: Marybeth S Hughes; Yik Y L Yu; Mark E Dudley; Zhili Zheng; Paul F Robbins; Yong Li; John R Wunderlich; Robert G Hawley; Morvarid Moayeri; STEVEN ROSENBERG; Richard A Morgan
Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions.
Human gene therapy 2005;16(4):457-72.
2004: Maria R Parkhurst; John P Riley; Takehito Igarashi; Yong Li; Paul F Robbins; STEVEN ROSENBERG
Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomerase.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(14):4688-98.
2003: Christopher E Touloukian; Wolfgang W Leitner; Rhonda E Schnur; Paul F Robbins; Yong Li; Scott Southwood; Alessandro Sette; STEVEN ROSENBERG; Nicholas P Restifo
Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(3):1579-85.
2002: Gang Zeng; Yong Li; Mona El-Gamil; John Sidney; Alexandro Sette; Rongfu Wang; STEVEN ROSENBERG; Paul F Robbins
Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design.
Cancer research 2002;62(13):3630-5.
2002: STEVEN ROSENBERG; Panida Tong-On; Yong Li; John P Riley; Mona El-Gamil; Maria R Parkhurst; Paul F Robbins
Identification of BING-4 cancer antigen translated from an alternative open reading frame of a gene in the extended MHC class II region using lymphocytes from a patient with a durable complete regression following immunotherapy.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(5):2402-7.
1997: Matthew Bloom; Donna Perry-Lalley; Paul F Robbins; Yong Li; Mona El-Gamil; STEVEN ROSENBERG; James C Yang
Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma.
The Journal of experimental medicine 1997;185(3):453-9.